Double-blind and Placebo-controlled Study on Intervention Effect of Medium and Long Chain Fatty Acid Triglyceride on Glycolipid Homeostasis in Patients With Metabolic Syndrome and Mechanisms
NCT ID: NCT06210230
Last Updated: 2024-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
240 participants
INTERVENTIONAL
2023-05-22
2023-12-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Olive Oil and MLCT on Glycolipid Homeostasis in Patients With Metabolic Syndrome
NCT05233917
Use of MCT Oil for Enhancement of Weight Loss and Glycemic Control in Obese Diabetic Patients
NCT00207233
Effect of a Mixed Macronutritional Meal With Medium Chain Triglycerides on the Oxidation of Postprandial Macronutrients
NCT04321018
Effects of Medium Chain Triglyceride Oil, Versus Olive Oil, for Weight Loss
NCT00529919
Evaluation of Medium Chain Triglycerides in a Mixed Racial Population of Patients: a Feasibility Study
NCT02783703
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Olive oil
Matching placebo (olive oil) 25g/d for 6 months
Intervention group
MLCT supplementation
MLCT 25g/d for 6 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MLCT supplementation
MLCT 25g/d for 6 months
Olive oil
Matching placebo (olive oil) 25g/d for 6 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Rarely eating out of home;
* Aged between 40 and 70 years.
Exclusion Criteria
* History of heart disease, coronary heart disease, stroke, cerebral infarction, viral liver disease (hepatitis A, hepatitis B, etc.), chronic kidney disease (GFR\<60 ml/min) or cancer;
* Diabetic ketoacidosis or hyperketosis;
* Drug use has changed in the past six months;
* Taking insulin;
* Used MLCT edible oil in the past six months;
* Have participated in other clinical trials in the last three months.
40 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yu Zhang
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lanxi Traditional Chinese Medicine Hospital
Jinhua, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RCT_MLCT_MetS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.